semaglutide 1.34 just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Ozempic Semaglutide Injection Pen for

10.1016/j.plaphy.2009.03.015 168 TakahashiM.TeradaY.NakaiI.NakanishiH.YoshimuraE.MoriS.et al

Larger doses of either medication showed greater changes in body weight

Common digestive side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and bloating

The approval of semaglutide marked a significant advancement in the pharmacological approach to managing obesity and diabetes, two of the most pressing public health concerns of our time

According to the FDA Adverse Events Reporting System (FAERS) Public Dashboard, there were 731 reports of pancreatitis and 39 reports of necrotizing pancreatitis from 2018 through 2024

Who can be prescribed Mounjaro under NICE guidance